Stocks

Beam Therapeutics BEAM

Health care sectorNasdaq

What to see in Beam Therapeutics now

Is Wall Street adding or cutting?+24

277 13F filers hold it · +24 against the quarter before · shares held +1.0%

Holdings of 06/30
Who bought more than 5%?9.9%

ARK Investment Management holds 9.95% · −2.3pp on the report before

Filed 08/14
What comes next?10/15 (Thu)

10/15 estimated earnings

Due 10/15
Close
$24.44
09/30 close
Day change
−0.3%
vs previous close
Volume
74,700
−12.4% vs 30-day average
52-week range
$20.23$37.98
1-year return
+0.3%
vs the close a year ago
Market cap
$2.5B
103,287,665 shares · reported 07/28

Company

Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, Massachusetts
Fiscal year end
12/31
Next earnings
10/15, estimated
  • 1 members of the National Assembly hold itPublished 03/26

Korean lawmakers

Korean Assembly members holding Beam Therapeutics in the 2026 disclosure.

MemberSharesFrom last yearEst. value
박해철더불어민주당 · 경기 안산시병119 shNew₩4.7M
Korean lawmakers' US stocks

Price

$24.44Day −0.3%1 year +0.3%

26-week trading